Anti-Bacterial Agents: Clinical Trials

28 trials for Anti-Bacterial Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 4 recruiting, 2 not yet recruiting, 2 unknown. 9 Not applicable, 5 Phase 4, 4 Phase 1, 3 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 7, Recruiting 1, Unknown 1
Phase 45Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 14Completed 4
Phase 23Completed 2, Terminated 1
Phase 32Completed 2

Follow Anti-Bacterial Agents: new trials by email Literature Review of Anti-Bacterial Agents trials Research Report on Anti-Bacterial Agents

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
Rifaximin - ACS - Acute Coronary Syndrome, Ticagrelor
Phase 4Not yet recruitingCollegium Medicum w Bydgoszczy502026-01-012025-10-02
The Impact of De-implementing Urine Dipsticks for Diagnosis of UTIs in Hospitals
De-implementation of Urinary Dipsticks, Usual practice with no intervention - Urinary Tract Infections, Diagnostic Techniques and Procedures
Not yet recruitingJacob Bodilsen4800002025-12-012025-10-01
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Pneumonia, Ventilator-Associated, Stenotrophomonas Maltophilia
RecruitingCentre Hospitalier de Saint-Denis3002023-12-152025-07-04
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
Amoxicillin/clavulanate, Ciprofloxacin, Clindamycin - Cat Bite, Hand Injuries
Phase 4RecruitingUniversity of Missouri-Columbia722023-09-072025-10-15
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem, Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor - Biliary Atresia, Cholangitis
Not applicableRecruitingChildren's Hospital of Fudan University3562023-07-012026-05-15
Use of Macrolides in Acute Chest Syndrome: A Multicenter Retrospective Study
Sickle Cell Disease, Acute Chest Syndrome
CompletedCentre Hospitalier de Saint-Denis2502023-06-012025-06-25
The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusion
target-controlled infusion (one of the administration methods), Standard administration method - Anti-bacterial Agents, Pharmacokinetics
Not applicableCompletedAsan Medical Center24942022-04-042025-09-25
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial
Azithromycin 1 gram IV, Cefazolin and indomethacin - Preterm Birth, Obstetric Labor, Premature
Phase 4UnknownThomas Jefferson University502021-12-202023-06-26
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
Antibiotics treatment - Periprosthetic Joint Infection, Anti-Bacterial Agents
RecruitingFirst Affiliated Hospital of Fujian Medical University5002021-12-012022-03-17
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis
Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD)
Phase 2 / Phase 3CompletedKarl Landsteiner Insitute for Nephrology and Haemato-Oncology122021-08-312025-08-11
Acute Application of Antibiotic Powder in Open Fracture Wounds
Vancomycin, Tobramycin - Fractures, Open, Wounds and Injuries--Infections
Phase 4CompletedUniversity of Colorado, Denver202021-06-142026-03-06
Neuroimmune Dysfunction in Alcohol Use Disorder
Minocycline, Sugar pill - Alcohol Drinking, Alcohol-Related Disorders
Phase 1CompletedUniversity of Maryland, Baltimore1422020-02-032023-12-01
Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty
Cephazolin, Sterile saline - Plastic Surgery, Mammaplasty
Not applicableCompletedDaniela Francescato Veiga1462019-08-042025-02-26
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
7-day course of antibiotics, 14-day course of antibiotics - Infant, Newborn, Neonatal SEPSIS
Phase 3CompletedIndian Council of Medical Research2612019-01-012023-11-02
Antibiotic, Gingival-biopsy, and Oral-smear Samples.
Sampling - Anti-bacterial Agents, Chromosome-defective Micronuclei
CompletedIstanbul Medipol University Hospital452018-10-152019-11-26
Improving Antimicrobial-Prescribing in Emergency Departments
Audit-and-feedback - Anti-Bacterial Agents, Respiratory Tract Infections
Not applicableCompletedIowa City Veterans Affairs Medical Center272018-10-092021-04-28
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
blood sampling, Tissue sampling (lung), Collection of fluid samples - Pharmacokinetics, Anti-Bacterial Agents
Not applicableUnknownUniversité Catholique de Louvain202018-03-152022-05-25
Influence of Perioperative Fluid Balance on Serum Concentrations of Antibiotics and Surgical Site Infections
Blood sampling after antibiotic administration - Antibiotic, Anti-Bacterial Agents
CompletedJohannes Gutenberg University Mainz1302018-03-142019-05-30
A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers
N-Rephasin® SAL200, INT200-Placebo - Healthy Volunteers, Anti-Bacterial Agents
Phase 1CompletedIntron Biotechnology, Inc.332018-02-072021-11-03
S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
drug product: capsules are containing S. boulardii, administered twice daily (250 mg) - Prevention & Control, Diarrhea Caused by Drug
Phase 4CompletedClinical Centre of Serbia962017-11-012022-03-02

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Respiratory Tract Infections (3)  ·  Bacterial Infections (2)  ·  Infections (2)  ·  Acute Chest Syndrome (1)  ·  Acute Coronary Syndrome (1)  ·  Alcohol Drinking (1)  ·  Alcohol-Related Disorders (1)  ·  Alcoholism (1)  ·  Anemia, Sickle Cell (1)  ·  Arm Injuries (1)  ·  Biliary Atresia (1)  ·  Chemically-Induced Disorders (1)  ·  Cholangitis (1)  ·  Cognition Disorders (1)  ·  Cognitive Dysfunction (1)

Broader conditions

Infections (9)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (6)  ·  Respiratory Tract Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Urogenital Diseases (3)  ·  Bacterial Infections and Mycoses (2)  ·  Behavior (2)  ·  Digestive System Diseases (2)  ·  Lung Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Urologic Diseases (2)

Interventions

Meropenem (3)  ·  Cefazolin (2)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Antigens, Differentiation (1)  ·  Azithromycin (1)  ·  Aztreonam (1)  ·  Blood Specimen Collection (1)  ·  Cefaclor (1)  ·  Cefpodoxime (1)  ·  Cefpodoxime Proxetil (1)  ·  Ceftriaxone (1)  ·  Ciprofloxacin (1)  ·  Clindamycin (1)  ·  Dosage Forms (1)  ·  Early Intervention, Educational (1)

Sponsors

Intron Biotechnology, Inc. (3)  ·  Centre Hospitalier de Saint-Denis (2)  ·  Asan Medical Center (1)  ·  Chiang Mai University (1)  ·  Children's Hospital of Fudan University (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Clinical Centre of Serbia (1)  ·  Collegium Medicum w Bydgoszczy (1)  ·  Daniela Francescato Veiga (1)  ·  Eskisehir Osmangazi University (1)  ·  First Affiliated Hospital of Fujian Medical University (1)  ·  Indian Council of Medical Research (1)  ·  Intermountain Health Care, Inc. (1)  ·  Iowa City Veterans Affairs Medical Center (1)  ·  Istanbul Medipol University Hospital (1)

Countries

United States (7)  ·  South Korea (4)  ·  China (2)  ·  France (2)  ·  Turkey (Türkiye) (2)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Germany (1)  ·  India (1)  ·  Norway (1)  ·  Poland (1)  ·  Serbia (1)

Top investigators

In Jin Jang, M.D., Ph. D. (2)  ·  Branislava Milenkovic, Prof, MD (1)  ·  Byung-Moon Choi, Ph.D. (1)  ·  Daniela F Veiga, MD, PhD (1)  ·  Hong-Bin Kim, M.D, PhD (1)  ·  Jacek Kubica, Prof. (1)  ·  Jason G. Newland, MD (1)  ·  Jenani S Jayakumaran, MD (1)  ·  Jennie H. Kwon, DO, MSCI (1)  ·  Kathy Goggin, PhD (1)  ·  Kevin M Klifto, DO, PharmD (1)  ·  Martin F Wiesholzer, MD (1)  ·  Nicholas Alfonso, MD (1)

Results publications

PMID 11739958, PMID 12808158, PMID 1444289, PMID 14576095, PMID 1482149, PMID 15979390, PMID 16304153, PMID 16531428, PMID 16640454, PMID 16776824, PMID 17135183, PMID 17846133, PMID 18788687, PMID 18824123, PMID 19095679, PMID 19237886, PMID 19398460, PMID 20561826, PMID 21142293, PMID 21730935, PMID 21788467, PMID 21862409, PMID 22194591, PMID 22491776, PMID 22839761, PMID 23153962, PMID 23299114, PMID 23894178, PMID 24080664, PMID 24731745, PMID 24768475, PMID 25433006, PMID 25455853, PMID 25712752, PMID 25753628, PMID 25808018, PMID 26188037, PMID 26414659, PMID 26603304, PMID 27242721, PMID 28348152, PMID 2875256, PMID 29743330, PMID 29790913, PMID 32553835, PMID 35007129, PMID 3588249, PMID 36410835, PMID 39780190, PMID 40280737

NIH funding

K01AA026005 (1)